Industry Pays Fees, FDA Should Deliver, Nissen Says Of Missed PDUFA Dates
Executive Summary
FDA is not keeping up its end of the user fee bargain and a first order of business for the new FDA commissioner should be to remedy that situation, according to Cleveland Clinic's Steven Nissen
You may also be interested in...
FDA Communication On Missed Deadlines Can Help Avoid Drug Review Limbo
Providing a new target decision date in tandem with missing a user fee review deadline would help FDA restore credibility and predictability to the review process, former FDA official Bruce Burlington suggests
FDA Communication On Missed Deadlines Can Help Avoid Drug Review Limbo
Providing a new target decision date in tandem with missing a user fee review deadline would help FDA restore credibility and predictability to the review process, former FDA official Bruce Burlington suggests
FDA Commissioner Search: Myths And Reality
Speculation about the next FDA head is well under way, but before it gets out of hand, here are five rules of thumb to keep in mind.